drugset / Trial / NCT00308399

A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.

NCT00308399

Phase 2/3 Completed 45 enrolled Mayo Clinic Axcan Pharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A 7 day study which involves 2 nutrient drink tests, an ECG, a Scintigraphy scan, and a Sect scan. This study requires the participant to make 4 visits to the GCRC in the Charlton building but no overnight stays.

Timeline

Start
2005-11
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Itopride Small molecule 100 mg Oral
Subject Itopride Small molecule 200 mg Oral

Indications

No indication recorded.